Upcoming Medical Conferences in CambridgeSearch Criteria : United States of America Cambridge
Oct 21 - 25, 2019 | CME 45.00 | USD $1795 | Cambridge, Massachusetts
Primary Care Internal Medicine 2019 is organized by Harvard Medical School (HMS), The Penzias Group and will be held from Oct 21 - 25, 2019 at Boston Marriott Cambridge, Cambridge, Massachusetts, United States of America. Accreditation: • 45.00 AMA PRA Category 1 CreditsTM • 45.00 ABIM MOC Points • 45.00 AAFP Prescribed credits • 11.50 Credits Risk Management Study, including: ○ 2.50 Credits of Opioid Education and Pain Management Training ○ 2.50 Credits of End-of-Life Care Studies ○ 1.25 Credits of Medical Use of Marijuana Training Updates Across All Major Areas of Primary Care and Guidance to Incorporate Them Into Practice for State-of-the-Art Patient Care This program provides a comprehensive update of the most important changes and advances impacting primary care and guidance to incorporate them into everyday clinical practice. What distinguishes this program is its practical and state-of-the-art focus on: • Optimizing patient care and outcomes for the wide range of conditions seen in primary care practice • Skills advancement for examination, diagnosis, treatment, and in-office procedures • Streamlined education that quickly and effectively provides the updates that are most important to primary care practice • New approaches to primary care clinical challenges (common and complex), including: ○ Hypertension: Navigating the conflicting recommendations ○ Diabetes: Treatment strategies for challenging cases ○ Cholesterol management: Setting targets and achieving goals specific to patient risk ○ Anticoagulation: Choosing the best anticoagulant for each patient ○ Disease prevention and health promotion ○ Biomodulators: Education expressly for primary care clinicians ○ Clinical examination skills: Improving your techniques ○ Opioids: Dosing, patient selection, addiction, and weaning ○ Medication interactions: Avoiding unintended interactions among medications prescribed by primary care clinicians and their consultants • The educational experience: ○ All lectures and skills development workshops are led by clinical faculty from Harvard Medical School, Massachusetts General Hospital, and other Harvard-affiliated hospitals. Faculty are leaders in more than 30 fields of medicine. ○ The learning experience is active and personalized. In addition to interactive lectures that span all major areas of primary care, you can choose from more than 48 knowledge- and skills-advancement workshops to customize a learning experience ideally suited to your specific interests. Guidance to Optimize Diagnosis, Treatment, and Clinical Outcomes The 2019 program provides updates, strategies, and best practices for primary care clinicians to optimize their approach to: • Cardiovascular disease • Diseases of the colon • Smoking cessation • Obesity • Hematologic disorders • Cerebrovascular disease • Asthma care • Pain control • Cholesterol management • Hypertension • Cognitive decline • Liver disease • Headaches of all types • Osteoporosis • Polyarthritis • COPD • Menopause management • Anticoagulant use • Kidney disease • GERD • Sleep disorders • Depression and anxiety Coverage includes updates and state-of-the-art approaches to examination, diagnosis, screening and management. Knowledge Advancement and Skills Development Workshops You can choose from 48 workshops to tailor the program to your specific practice needs. This year’s workshops include: • Pain management • Preoperative evaluation • Complex diabetes • Medical marijuana • Suturing techniques • Otolaryngology • Dermatology • Ophthalmology • Movement disorders • Gynecology • Allergies • GI cases • Thyroid disorders • Prostate conditions • Joint examination skills • Dementia and delirium • Incontinence management • Travel medicine Learning Objectives: Upon completion of this course, participants will be able to: • Develop new and innovative skills in clinical problem-solving to achieve the best outcomes for all patients • Evaluate updated guidelines for the care of the most common conditions of outpatient practice: hypertension, diabetes and hypercholesterolism • Design practical and effective approaches to behavioral issues including partner violence, alcohol and marijuana misuse, and opioid addiction • Assess the clinical value of specific diagnostic tests used in general internal medicine and specialty practices, including test sensitivity, specificity and predictive values • Identify the disease prevention and health promotion priorities of general internal medicine • Recognize the side effects and interactions among medications prescribed by primary care clinicians and their consultants • Develop a working understanding of biomodulators and the interactions of these novel agents with the medications prescribed in primary care practice • Discuss the expected results of therapies and summarize current treatment strategies for cardiovascular, pulmonary, neurologic/neurovascular, endocrine, ophthalmic, orthopedic, immunologic, reproductive, dermatologic, gastrointestinal, hepatic, geriatric, psychiatric, metabolic, and sleep medicine conditions • Describe optimal pain control, including opioid management and buprenorphine treatment • Apply evidence-based palliative care strategies in clinical practice • Explain how national payment policies impact primary care practice • Demonstrate clinical examination skills • Integrate lifestyle messages into daily practice and self-care • Develop a renewed understanding of how to best manage the stresses that are part of your professional commitment to patient care, continuity, and access
Oct 21 - 25, 2019 | CME 34.25 | USD $1345 | Cambridge, Massachusetts
27th Annual Update Neurology 2019 is organized by Harvard Medical School (HMS), The Penzias Group and will be held from Oct 21 - 25, 2019 at Royal Sonesta Boston, Cambridge, Massachusetts, United States of America. Who Should Attend: • Neurologists • Psychiatrists • Internists • Family Physicians • Nurse Practitioners • Physician Assistants • Residents • Fellows ...and other medical professionals who want a comprehensive clinical update of state-of-the-art practices for outpatient and inpatient neurology Accreditation: The Harvard Medical School designates this live activity for a maximum of 34.25 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. • Main Course, Neurology 2019: 30.75 AMA PRA Category 1 Credits™ • Neurologic Pain Workshop: 3.50 AMA PRA Category 1 Credits™ Risk Management This activity meets the criteria of the Massachusetts Board of Registration in Medicine for 1.25 credits of Risk Management Study Course Description: Neurologists, primary care providers and specialists who diagnose and treat neurological conditions can rely on this program for a comprehensive, evidencebased review of state-of-the-art practices for outpatient and inpatient neurology. Education covers the latest guidelines, clinical strategies, and recent advances, including the use of genetic tests, optimal use of imaging, new approaches for diagnosis, and expanded options for treatment for a wide array of neurological diseases. Education is practical and focused on patient outcomes. Led by the foremost authorities in neurology subspecialties, the program provides tools to improve your care of patients with common, complex, and rare neurological conditions. As updates are presented, they are paired with specific practice recommendations to help you optimize patient care and outcomes. Lectures are designed to be engaging and to quickly and effectively transfer knowledge. Comprehensive Updates and State-of-the-Art Practices for Outpatient and Inpatient Neurology This program provides a comprehensive, evidence-based review of state-of-the-art practices for outpatient and inpatient neurology. Education covers the latest guidelines, clinical strategies, use of imaging and new diagnostic tools (including genetic tests), and recent advances for treatment for a wide array of neurological diseases. Education is practical and focused on patient outcomes. Led by the foremost authorities in neurology and its subspecialties, the program provides tools to improve your care of patients with common, complex, and rare neurological conditions: • Epilepsy • Stroke • Multiple Sclerosis • Concussions • N-M Junction Disorders • Alzheimer's Disease • Parkinson’s Disease • Neuro-oncology • Headache • Spinal Cord Neurology • Cerebellar Ataxias • Pain • Dementia • Neuropathy • Movement Disorders • Coma • Neuropsychiatry • Visual Disturbances • Autoimmune Neurology • Neuro-infectious Disease • Women’s Neurology • Neuro-ophthalmological Disorders As updates are presented, they are paired with specific practice recommendations to help you incorporate them into practice for improved patient care and outcomes. This includes: • The new guidelines for epilepsy, stroke, neuromuscular disorders • Comprehensive updates for treatment of neurologic pain • Expert instruction for neuro-ophthalmology • Expanded options to diagnose and treat dementia • Improved management of headache • Best practices for treatment of neurologic autoimmune disorders • Steps to ensure delivery of high-quality care in the emergency room and in outpatient settings • Techniques to effectively manage epilepsy and psychogenic non-epileptic seizures • Best practices in neuro-oncology • New insights and best practices for myelopathy and other spinal cord disorders • Expanded options to treat movement disorders • Updates in neuro-infectious disease • State-of-the-art approaches to concussion and coma • Expanded options to diagnose and treat cerebellar ataxias • Alcohol and the nervous system: what we now know • Use of genetic tests • Optimal use of imaging Practice-Changing Education Every year, there are a staggering number of critically important updates that need to be understood and incorporated into the practice of neurology to ensure optimal patient care. This special neurology update synthesizes this vast amount of information and presents it with efficiency and effectiveness to ensure that you are current with these updates and the best ways to incorporate them into practice. Over the course of a week, you will be immersed in an impactful and inspiring neurology learning experience. The faculty, master clinicians and leaders in field of neurology, provide a learning experience that delivers: • Approaches that enable you to practice state-of-the-art neurology • Guidance for clinical reasoning • Case studies • Dedicated time for you to pose your specific questions to leaders in their respective fields of neurology and delve into how information presented in this course can be used in your specific clinical setting Optional Half-Day Workshop State-of-the-Art Treatments of Neurologic Pain Friday, October 25, 1:00 pm - 5:00 pm This special workshop teaches state-of-the-art approaches to pain management. You will learn the most current treatments available, and receive targeted guidance to optimize your care for your patients with neurologic pain. Highlights include: • New treatment options for chronic migraine • Best practices for the care of patients with neck and back pain • Updates in the evaluation and treatment of complex regional pain syndrome and other autonomically mediated pain syndromes • How, when and why to use local nerve blocks • Best ways to partner with an anesthesiologist in treating pain Practical knowledge that you can “take home” and immediately apply to patient care Year after year, attendees report they are inspired by the knowledge transfer and find the experience to be invaluable to their clinical practice, understanding of neurologic diseases, diagnostic skills and treatment outcomes.
Nov 02, 2019 | Cambridge, Massachusetts
Practicing Clinicians Exchange (PCE) 2019 Symposia is organized by Practicing Clinicians Exchange (PCE) and will be held on Nov 02, 2019 at Boston Marriott Cambridge, Cambridge, Massachusetts, United States of America. Topics Include: Asthma, Atopic Dermatitis, Diabetes, Endometriosis, Influenza, Insomnia, and Lupus Additional details will be posted as soon as information is available.
Nov 08 - 10, 2019 | CME 20.00 | USD $895 | Cambridge, Massachusetts
Diabetes and Its Complications is organized by Harvard Medical School (HMS), The Penzias Group and will be held from Nov 08 - 10, 2019 at Boston Marriott Cambridge, Cambridge, Massachusetts, United States of America. Who Should Attend: • Internists • Family Physicians • Hospitalists • Endocrinologists • Geriatricians • Nurse Practitioners • Physician Assistants • Certified Diabetes Educators Accreditation: • 20.00 AMA PRA Category 1 Credits™ • 20.00 ABIM MOC points • 19.75 AAFP Prescribed credits • 4.75 credits of Risk Management Study Updates, Guidance, and Best Practices to Optimize Care for Patients with Diabetes: This Harvard Medical School CME program provides comprehensive updates, practice recommendations, and the newest evidence-based strategies for the treatment and care of the person with or at risk for diabetes. One of Harvard Medical School's highest-rated CME courses, it will ensure that you are current with state-of-the-art approaches to: • Diabetes screening • Pharmacological management of diabetes, including insulin and non-insulin treatments • The latest advances in insulin delivery and glucose monitoring • Treating complications and comorbidities, including dyslipidemia, hypertension, obesity, peripheral vascular disease, cardiovascular disease, the diabetic foot, kidney disease, liver disease • Lifestyle interventions • Care of older patients with diabetes • Incorporating recent advances into your practice • Challenging cases Education to Optimize Patient care and Outcomes: Education is focused on optimized patient care and outcomes and improving skills in the following areas: • Insulin initiation and intensification: which insulins to choose and why • Understanding the new insulins, glucose monitors, and pumps • Treating people with type 2 diabetes who are not achieving therapeutic goals • Office-based assessment and treatment of comorbidities and complications • Individualizing multifaceted approaches to lifestyle modification and weight management • Personalizing nutrition plans and exercise prescriptions • Cardiovascular risk reduction and care • Optimal management of neuropathies and foot disease • Managing diabetes in high-risk populations, including pregnant patients and the elderly • Understanding the evolving concepts and treatments that will soon impact your day-to-day practice • Communicating with, motivating, and sharing resources with patients Learning Objectives: Upon completion of this course, participants will be able to: • Describe how advances in our understanding of pathophysiology and natural progression of type 1 and type 2 diabetes have resulted in a more integrated consideration of comorbidities in the design of glycemic treatments; • Identify strategies to optimize the impact of lifestyle interventions in the treatment of diabetes and related conditions; • Summarize appropriate, evidence-based treatment guidelines from recognized, expert organizations for the treatment of diabetes; • Discuss new and evolving pharmacologic and electronic tools that currently or potentially impact the treatment design, efficacy, and/or safety of glycemic control programs; • Demonstrate skills in advancing therapies for glycemic control aimed at achieving recommended treatment targets; • Identify strategies to care for patients with diabetes-related comorbidities and complications based on updated knowledge of state-of-the-art treatment advances; • Explain strategies to identify and then overcome clinical practice barriers emanating from patients, providers, and practice systems issues.
Nov 12, 2019 | Cambridge, Massachusetts
Bioinformatics Strategy Meeting East Coast USA 2019 is organized by Proventa International and will be held on Nov 12, 2019 at Le Meridien Boston Cambridge, Cambridge, Massachusetts, United States of America. Course Description: Redefining the way global business leaders build meaningful partnerships, Proventa International’s Bioinformatics Strategy Meeting aims to offer more value than typical bioinformatics conferences. Exclusive to primary decision makers of top and emerging biotech, pharma and IT companies, our strategy meeting guarantees that you meet and engage with c-level directors only. While bioinformatics summits can provide brand awareness by putting you in front of a huge audience, you may find that opportunities to share your experience or ideas are quite limited. In our Bioinformatics Strategy Meeting, we focus on in-depth exploration of bioinformatics trends and topics that matter to you. Through our executive roundtable discussions, delegates with shared key challenges are grouped together to discuss topics like data management/analytics, next-generation sequencing, artificial intelligence and more. These intimate 60-minute sessions scheduled throughout the day allow everyone to raise relevant questions or contribute insightful experiences. If you have been attending bioinformatics conferences, you may be aware that, with the varied levels of experience and seniority of other attendees, it may be difficult to find someone you can consult with about your strategic priorities. Not with the Bioinformatics Strategy Meeting. Our pre-scheduled one-to-one meetings connect you with a subject matter expert who will work with you to help achieve short to long-term goals. Need guidance on optimizing processes in computational biology? With our vast network of medical informatics experts here in California and around the globe, you can be sure to meet the right match! Business leaders who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for: • R&D Information Technology • Computational Biology/Sciences • Cloud Computing • Next-Gen Sequencing Informatics • Clinical Research • Translational Informatics • Clinical Genomics • Data & Storage Management • Data Computing • Data Visualization & Exploration Additional details will be posted as soon as they are available.
Nov 13, 2019 | Cambridge, Massachusetts
Biology Strategy Meeting East Coast USA 2019 is organized by Proventa International and will be held on Nov 13, 2019 at Le Meridien Boston Cambridge, Cambridge, Massachusetts, United States of America. Course Description: Creating an interactive environment where business leaders worldwide can explore partnerships, Proventa International’s Biology Strategy Meeting is unlike regular biology conferences. With director-level executives from Boston and around the world attending, you can be sure you only meet and engage with primary decision makers from large and emerging biotech, pharma and IT organizations. While biology conferences or life science summits get you in front of a huge pool of industry professionals with varied level of experience and seniority, you may find that opportunities to raise relevant questions or share personal insights are limited. That is not the case with our Biology Strategy Meeting. Via our executive roundtable discussions, you are encouraged to dive deep into topics that matter to you like DMPK & ADME, In Vivo & In Vitro Pharmacology, Biophysics, Toxicology and other biology trends. These 60-minute discussions also allow for bringing up queries or sharing of helpful industry insights. Another feature that makes us different from other biology events is our pre-scheduled one-to-one meetings. With our wide network of experienced biology experts in the United States and around the world, you can be sure to meet the right professional who can help you create strategies in solving your organization’s challenges. Need guidance on in vivo and in vitro pharmacology? Contact us so we can start looking for the right subject matter expert! Business leaders who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for: • Drug Discovery • Lead Optimization • ADME screening • In vitro metabolism • Assay Development • Strategy and Portfolio Solutions • Strategic Partnership & Alliance • Drug/Product Safety Additional details will be posted as soon as they are available.
Nov 14, 2019 | Cambridge, Massachusetts
Medicinal Chemistry Strategy Meeting East Coast USA 2019 is organized by Proventa International and will be held on Nov 14, 2019 at Le Meridien Boston Cambridge, Cambridge, Massachusetts, United States of America. Coures Description: Recreating how business leaders build meaningful partnerships, Proventa International’s Medicinal Chemistry Strategy Meeting is not like typical biochemistry conferences in the United States. Exclusive to c-level executives only, our strategy meeting gathers primary decision makers from large and emerging biotech and pharma organizations to discuss strategic challenges and share industry insights. Our interactive executive roundtable discussions allow for in-depth exchanges on medicinal chemistry trends and topics. Every attendee is encouraged to raise relevant questions and contribute innovative ideas to the conversation, something that might prove to be a challenge at medicinal chemistry conferences. Another feature you can’t find in biochemistry summits is our pre-scheduled one-to-one meetings. Personalized to your business needs and goals, this session connects you with an industry expert to tackle and come up with strategies to overcome high-priority issues. Looking for the latest medicinal chemistry tech trends? Contact us today to schedule you with a subject matter expert! Business leaders who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for: • Immunology Chemistry • Chemistry Technologies • Medicinal and Innovative Chemistry • Drug Discovery & DMPK • Chemical Therapeutics & Development • Molecular Pharmacology & Therapeutics • Computational and Structural Chemistry • Biochemistry Additional details will be posted as soon as they are available.
Nov 19, 2019 | Cambridge, Massachusetts
Clinical Operations Strategy Meeting East Coast USA 2019 is organized by Proventa International and will be held on Nov 19, 2019 at Le Meridien Boston Cambridge, Cambridge, Massachusetts, United States of America. Course Description: Creating an interactive space where business leaders can discuss strategic priorities, Proventa International’s Clinical Operations Strategy Meeting differs from regular clinical operation conferences. Unlike clinical outsourcing summits, our strategy meeting is exclusive to c-level executives from top and emerging biotech, pharma and IT companies. If you’re looking to speak to primary decision makers about key issues in the industry, then this is the place to be. While attending medical operation conferences gets you in front of big audiences, the chances to raise questions or share ideas are limited. Our executive roundtable discussions allow in-depth conversations about clinical operation trends and topics like clinical trials, clinical outsourcing, patient recruitment, eTMF and more. Intimate and personalized, these sessions give each delegate a chance to ask relevant questions and contribute great insights on shared challenges that they face. Another feature of our strategy meeting is the pre-scheduled one-to-one meetings. Looking for ways to optimize your clinical data management processes? Contact us and we’ll connect you with the right subject matter expert from our vast network of experienced clinical operation professionals worldwide. Business leaders who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for: • Clinical Operations • Data Sciences • Clinical Outsourcing • Patient Recruitment • eTMF • Safety Data Management • Clinical Trial Management • Data Acquisition Technology • Pharmacology Scientific Operations • Clinical Informatics and Innovation Additional details will be posted as soon as they are available.
Nov 20, 2019 | Cambridge, Massachusetts
Pharmacovigilance Strategy Meeting East Coast USA 2019 is organized by Proventa International and will be held on Nov 20, 2019 at Le Meridien Boston Cambridge, Cambridge, Massachusetts, United States of America. Course Description: Designed to connect business leaders worldwide, Proventa International’s Pharmacovigilance Strategy Meeting does a different approach to bringing organizations the latest regulatory updates and drug safety insights. Unlike other pharmacovigilance conferences, our strategy meeting is exclusive to director-level executives from large and emerging biotech, pharma and IT companies so you can be sure you’re engaging with primary decision makers. If you’ve been attending drug safety summits or regulatory affairs conferences, you know that the opportunities to raise questions relevant to your business are limited. With the personalized format of our executive roundtable discussions, we assure in-depth discussions of issues that your organization is facing. Delegates with shared key challenges are grouped together to dive deep on pharmacovigilance trends and topics like epidemiology, risk monitoring clinical and patient safety and more. Everyone gets the chance to ask questions or contribute insights to the session. With the goal to offer more value to our delegates, our pre-arranged one-to-one meetings are another feature you can’t find in pharmacovigilance conferences. Need guidance on medical and regulatory affairs? Contact us and we’ll schedule your one-to-one meeting with an experienced professional from our wide network of pharmacovigilance consultants worldwide. Business leaders who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for: • Pharmacovigilance • Risk Management • Drug Safety • Safety Surveillance • Clinical & Patient Safety • Medical & Regulatory Affairs • Compliance • Post Authorisation Safety • Medical Safety • Epidemiology Additional details will be posted as soon as they are available.
Nov 21, 2019 | Cambridge, Massachusetts
Regulatory Affairs Strategy Meeting US East Coast 2019 is organized by Proventa International and will be held on Nov 21, 2019 at Le Meridien Boston Cambridge, Cambridge, Massachusetts, United States of America. Coures Description: Designed to build meaningful partnerships among business leaders worldwide, Proventa International’s Regulatory Affairs Strategy Meeting is not like most pharmaceutical regulatory affairs conferences. With all the delegates pre-qualified, you can be sure that you only meet and engage with primary decision makers of top and emerging biotech, pharma, IT and academic organizations. While regulatory affairs conferences expose you to huge pools of industry professionals with varied levels of experience and seniority, our Regulatory Affairs Strategy Meeting aims to provide insightful conversations with director-level executives. Another feature you can’t find in regulatory affairs events is our executive roundtable discussions. Personalized for each delegate, these discussions allow of in-depth exchanges on pharmaceutical regulation updates, industry trends and strategic challenges. These 60-minute sessions also give way for anyone who wants to raise their questions or share their expertise. Our Regulatory Affairs Strategy Meeting also lets you meet expert/s to help you strategize for short and long-term goals via our pre-scheduled one-to-one meetings. Depending on your strategic priorities, we connect you with the right professional from our vast network of pharmaceutical regulation experts in Boston and around the globe. Need help with CMC or Regulatory Operations? Contact us today so we can connect you with a subject matter expert! Business leaders who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for: • Chemical Candidate Selection • Data Package Completeness • Risk Assessments • Regulatory agency interaction • Premarket approvals Labeling • Advertising • Clinical Evaluation • Postmarket Surveillance • Orphan Drug Submissions • Facility Inspections • Pricing and Market Authorisation Approval • Product Life Cycle Management • Quality review • Clinical trial applications • Marketing applications • Compliance Change Control Additional details will be posted as soon as they are available.